The government provides Evusheld to states based on their total adult populations. The approach doesn't prioritize where the need is greatest.
What does society owe immunocompromised people?
Experts are hopeful that this preventive medication, taken before any exposure to COVID-19, will provide an extra layer of protection to those who may not mount a full immune response to the vaccine.
This is where I lose sleep. The health of immunocompromised people depends on far more than a Covid-19 booster shot.
What they —and the rest of us — need is more people in the general population to be vaccinated, and quickly,
Some immunocompromised people feel left out of the narrative.
Dr. Lindsay Ryan is passionate about getting people vaccinated. She trains college students to go out into communities and just talk to people about it, listen to their concerns, always with the goal of getting more shots in arms. But this work is hard for her, too, because although the vaccines are highly effective in the vast majority of people, they don’t work on her—she has an autoimmune condition.
Early on in the pandemic, researchers learned that immunocompromised people infected with COVID-19 tend to have particularly severe and long-lasting infections. This leads to prolonged viral shedding, meaning that the period during which these infected people release the virus as they breathe, talk and eat is much longer. Thus, they have a higher chance of transmitting the virus to others.
Experts call for tighter precautions, better treatments, more research.
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
For the immunocompromised, the pandemic has been scarier, riskier, and longer. And with vaccines not offering safety, the question is: What will?
For months we’ve been fixated on the idea that some people are at “high risk” and others aren’t. Now scientists have a better understanding of the continuum.
For some people, life won't go back to normal when we're all allowed to go back outside.
Right now Americans are working on how to negotiate daily life in the cloud of the coronavirus, but for those who have a compromised immune system, each decision is all the more fraught, since one misstep could prove deadly.
Here’s how to shorten the isolation of our most vulnerable citizens.
The Moderna vaccine also offered more protection to people with weakened immune systems than did the Pfizer shot, mirroring results seen across American adults. And certain people with immune deficiencies — especially organ or stem cell transplant recipients, who often take drugs to suppress their immune systems and prevent rejection of the transplant — showed weaker responses to Covid vaccines than other categories of immunocompromised people did.
There's mounting research to suggest that protecting people who are immuno-compromised from getting COVID is important not just for their sake – it could be critical in the effort to end the pandemic for everyone.
The evidence comes from two separate strands of studies.
The COVID-19 pandemic has held an extra layer of uncertainty for immunocompromised people, who in some cases face an increased risk of contracting severe disease.
A new use of a familiar—and coveted—drug might be our ticket out.
But he stresses that people who are immunocompromised are not a monolithic group. Some patients are responding well to COVID-19 vaccines. And even for those who are not, like people who have undergone organ transplants, there's hope in new medications like Paxlovid, Pfizer's pill.
Immunocompromised individuals may also be at risk of losing out to coronavirus through indirect competition for treatment and the medications that allow them to lead relatively normal lives.
Elizabeth Groenweghe got a kidney transplant 14 years ago. She now takes several medications to prevent her body from rejecting her transplant organ. But these medications also weaken her immune system, putting her at higher risk of becoming seriously ill if she catches covid-19.
FDA expected to issue full emergency authorization for periodic antibody injections, or PrEP, to complement vaccinations.
People with moderately to severely compromised immune systems are especially vulnerable to COVID-19, and may not build the same level of immunity to 2-dose vaccine series compared to people who are not immunocompromised.